695
Participants
Start Date
September 7, 2017
Primary Completion Date
January 30, 2023
Study Completion Date
January 30, 2023
Benralizumab
Benralizumab subcutaneously on study week 0 until study week 40 inclusive.
Placebo
Placebo subcutaneously on study week 0 until study week 40 inclusive.
Research Site, Taipei
Research Site, Taipei
Research Site, Taipei
Research Site, Taoyuan
Research Site, Manila
Research Site, Iloilo City
Research Site, Hohhot
Research Site, Uijeongbu-si
Research Site, Seongnam-si
Research Site, Baotou
Research Site, Bucheon-si
Research Site, Suwon
Research Site, Wŏnju
Research Site, Daejeon
Research Site, Changzhi
Research Site, Busan
Research Site, Gwangju
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Shenyang
Research Site, Shenyang
Research Site, Qingdao
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Nanjing
Research Site, Nanjing
Research Site, Xuzhou
Research Site, Xuzhou
Research Site, Yangzhou
Research Site, Taizhou
Research Site, Qingdao
Research Site, Jining
Research Site, Hangzhou
Research Site, Hangzhou
Research Site, Hangzhou
Research Site, Hangzhou
Research Site, Lishui
Research Site, Nanchang
Research Site, Ganzhou
Research Site, Chongqing
Research Site, Wanzhou
Research Site, Changsha
Research Site, Changsha
Research Site, Xiangtan
Research Site, Wuhan
Research Site, Xinxiang
Research Site, Guangzhou
Research Site, Guangzhou
Research Site, Guangzhou
Research Site, Guangzhou
Research Site, Zhuhai
Research Site, Zhanjiang
Research Site, Foshan
Research Site, Guiyang
Research Site, Zunyi
Research Site, Haikou
Research Site, Chengdu
Research Site, Chengdu
Research Site, Neijiang
Research Site, Kunming
Research Site, Kunming
Research Site, Yinchuan
Research Site, Yinchuan
Research Site, Nanjing
Research Site, Hohhot
Research Site, Taiyuan
Research Site, Cheonan
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Lead Sponsor
AstraZeneca
INDUSTRY